First Canadian Summit on

The Summit Program

This is a CME accredited event

Target Audience:

General Surgeons, Endocrinologists, Family Medicine, Diabetes Educators, Nurses, Nutritionists, Psychologists, Kinesiologists, Public Policy Makers, Patient Group Advocates

Honorary Chairs:

Dr. L. D. MacLean, McGill University
Dr. P. Marceau, Université de Laval

Program Chairs

Dr. Nicolas V. Christou, McGill University
Dr. F. Rubino, Cornell University

The First Canadian Summit on Surgery for T2DM is presented by the Section of Baraitric Surgery, Division of General Surgery, McGill University and the Continuing Education Office of the MUHC, in association with the Centre of of Continuing Medical Education, Faculty of Medicine, McGill University

Thursday, May 6, 2010

8:00am to 5:00pm

8:00	Welcome Remarks
	MSSS Representative The Hon. Arthur T. Porter, MD Director General, McGill University Health Centre
	Introductory Remarks by the Chair Dr. Nicolas Christou, McGill University, CANADA
8:45	The problem – “Globesity” and Type II diabetic patient and society implications Moderator: Dr. Arya Sharma, University of Alberta, CANADA Objectives: Discuss the epidemiology, pathophysiology and socio-economic burden of obesity and diabetes in Canada in relation to the rest of the world. Examine the cardiovascular and overall risk factors of T2DM. Discuss established and novel therapies available to treat T2DM.
8:45	The world obesity epidemic and associated diseases, including Type II diabetes – a chronic disease that is difficult to treat Dr. Arya Sharma, University of Alberta, CANADA
9:30	Metabolic Syndrome and Cardiovascular Risk Factors – Clinical evidence and best medical therapy options Dr. Jacques Genest, McGill University, CANADA
10:05	Established and novel pharmacologic therapies for T2DM – Outcomes and limitations Dr. David C. Lau, University of Alberta, CANADA
10:40	An Economic Tsunami: The cost of diabetes in Canada (CDA report December 2009) Margaret Beatty, Vice President, Research, Professional Education and Government Affairs with the Canadian Diabetes Association
11:15	Panel Discussion
12:15	Lunch Break and Exhibition
2:00	Surgical Therapy for Severe Obesity and associated chronic diseases – What are the results? Moderator: Dr. Mehran Anvari, McMaster University, CANADA Objectives: To review the clinical evidence to date in support of the surgical management of severe obesity and T2DM.
2:00	Bariatric (Metabolic) Surgery for life-long weight control and remission of associated chronic diseases - A metanalysis of published clinical papers to date Dr. Henry Buchwald, Minneapolis, USA
2:35	Bariatric (Metabolic) Surgery for life-long weight control and mortality risk reduction Dr. Ted Adams, University of Utah, USA
3:10	Bariatric (Metabolic) Surgery for life-long weight control and reduction in healthcare costs Dr. John Sampalis, McGill University, CANADA
3:45	Panel Discussion

Friday, May 7, 2010

8:00am to 5:00pm

8:00	Bariatric (Metabolic) Surgery for treating T2DM – What is the evidence?
	Moderator: Dr. Francesco Rubino, Cornell University, USA Objectives: To present evidence to support the use of Metabolic (Bariatric) surgery for life-long remission of T2DM
8:00	Animal models and human studies – GI Hormone secretion and function after metabolic (bariatric) surgery and their role in diabetes Dr. Francesco Rubino, Cornell University, USA
	Surgical Technique and Outcomes for T2DM – Which is best? The “15-minute pitch”
8:50	Gastric Banding Dr. Chris Coburn, University of Toronto, CANADA
9:10	Gastric Bypass Dr. Ricardo Cohen, BRAZIL
9:30	Biliopancreatic diversion with Duodenal Switch (BPDDS) Dr. Alphons Pomp, Cornell University, USA
9:50	Sleeve Gastrectomy Dr. Shahzeer Karmali, University of Alberta, CANADA
10:10	Ileal Interposition / Duodenal Exclusion Dr. Francesco Rubino, Cornell University, USA
10:30	Endoluminal duodenal-jejunal sleeve fat reduction, The future.... Dr. Ricardo Cohen, BRAZIL
10:50	Why surgical treatment of diabetes may not be a good option? Dr. David C. Lau, University of Alberta, CANADA
11:10	Panel discussion
12:00	Lunch Break & Exhibition
1:30	Where does Canada go from here?
	Moderator: Dr. Nicolas Christou, McGill University, CANADA Objectives: To debate whether Medicare, (single-payer health care system) and private insurers for diabetes treatment by current medical therapy should increase capacity for Metabolic (Bariatric) surgery across Canada
1:30	Access to Bariatric (Metabolic) Surgery in Canada – Is there a problem? Dr. Nicolas Christou, McGill University, CANADA
2:00	Cost Effectiveness of Surgery for T2DM Dr. A. Ghosh, Analysis Group, Inc., USA
2:30	Bariatric (Metabolic) Surgery must be “delivered” safely with minimal complications Dr. John Hagan, University of Toronto, CANADA
3:00	Medical and Surgical T2DM treatment strategy – The Ontario Experience Dr. Mehran Anvari, McMaster University, CANADA
3:30	Panel Discussion
	• Endocrinologists • Government representatives • Insurance underwriters	• Health economists • Patient interest group • Senior hospital administrators
5:00	Adjournment